San Diego, CA, United States of America

Tocagen Inc.


USPTO Granted Patents = 12

% Expired Patents = 41.7



Forward Citations = 22

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Douglas J Jolly (12 out of 53 patents)

silverMedal Harry E Gruber (10 out of 47 patents)

bronzeMedal Omar D Perez (6 out of 6 patents)

4 Christopher R Logg (5 out of 14 patents)

5 Kay Olmstead (3 out of 19 patents)

6 Amy Lin (2 out of 16 patents)

7 Derek G Ostertag (2 out of 4 patents)

8 Joan M Robbins (2 out of 4 patents)

9 Tiffany Huang (2 out of 2 patents)

10 Ryan Burnett (1 out of 3 patents)

11 Carlos E Ibanez (1 out of 8 patents)

12 Noriyuki Kasahara (21 patents)

13 Amy H Lin (0 patent)


12 patents:

Tocagen Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing gene therapies to treat cancer. Their proprietary gene therapy platform is designed to selectively deliver therapeutic genes into cancer cells, enabling targeted treatment. Tocagen aims to improve the lives of patients with difficult-to-treat forms of cancer by providing innovative and specialized therapies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Tocagen Inc.
12 Patents

#444 in San Diego, CA

#6,047 in California

#25,496 in US

#48,036 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 22

11 inventors:

Please report any incorrect information to [email protected]
Loading…